Down-regulation of VDAC1 and/or preventing its interaction with Aβ and phosphorylated tau could potentially preserve mitochondrial function, slow the progression of AD, and ultimately improve cognitive function in patients (Cuadrado-Tejedor et al., 2011; Manczak and Reddy, 2012). The gene discussed is VDAC1; the disease is Alzheimer disease.